Related Experiment Video
Updated: Jun 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells
Michael Pohl1, Yvonne Radacz, Nicole Pawlik
1Department of Medicine, Knappschafts krankenhaus, Ruhr-University, In der Schornau 23-25, 44892 Bochum, Germany.
Background:
Inactivation of the tumour suppressor gene SMAD4 is a genetically late event in gastrointestinal carcinogenesis. SMAD4 is a transmitter of growth-inhibitory effects of transforming growth factor-beta (TGF-beta), an important tumour promoter capable of inducing an epithelial to mesenchymal transition (EMT). The role of SMAD proteins in late, tumour-promoting effects of TGF-beta is not well understood.
Materials And Methods:
The change of molecular differentiation markers typical for EMT upon SMAD4 re-expression in SW480 cells was determined using Western blotting, immunohistochemistry and confocal laser microscopy. The influence of SMAD4 on the migration of SW480 cells was assessed in wound healing and pore migration assays.
Results:
SMAD4 suppresses invasiveness and mediates reversion of SW480 cells from a mesenchymal-like to a polarized epithelial phenotype, with features of enterocyte-like differentiation. Moreover, SMAD4 reconstitution was associated with down-regulation of endogenous TGF-beta cytokines, suggesting that autocrine TGF-beta signaling may be involved in the EMT.
Conclusion:
These results provide further evidence for a role of SMAD4 as a regulator of invasion, a process of prime importance in carcinogenesis but hitherto poorly understood in molecular terms.
Insights
Re-expressing the SMAD4 gene suppresses tumor cell invasion and reverts cells to an epithelial state, suggesting its role in controlling cancer progression. This finding enhances understanding of gastrointestinal carcinogenesis.
Area of Science:
- Molecular Biology
- Cancer Research
- Gastrointestinal Carcinogenesis
Background:
- SMAD4 gene inactivation is a late event in gastrointestinal cancer.
- SMAD4 transmits TGF-beta's growth-inhibitory effects.
- The role of SMAD proteins in TGF-beta's tumor-promoting effects is unclear.
Purpose of the Study:
- To investigate the role of SMAD4 in epithelial-mesenchymal transition (EMT).
- To understand SMAD4's function in regulating cell invasion and differentiation.
Main Methods:
- Western blotting, immunohistochemistry, and confocal microscopy assessed differentiation markers.
- Wound healing and pore migration assays evaluated cell migration.
Main Results:
- SMAD4 re-expression suppressed invasiveness and promoted reversion to an epithelial phenotype.
- SMAD4 mediated enterocyte-like differentiation.
- SMAD4 reconstitution reduced endogenous TGF-beta, suggesting autocrine signaling in EMT.
Conclusions:
- SMAD4 acts as a regulator of invasion in carcinogenesis.
- These findings offer molecular insights into a poorly understood aspect of cancer development.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mesenchymal Stem Cells
Renewal of Intestinal Stem Cells

